Anticholinergic Poisoning: Physostigmine and Its Cautions

One switch, one whole syndrome

Block the muscarinic receptor and you silence half the autonomic nervous system at once. Acetylcholine acting on muscarinic receptors is the workhorse of the parasympathetic "rest and digest" system: it constricts the pupil, drives the sweat glands (an anatomical oddity — sweating is a sympathetic function but runs on acetylcholine), keeps secretions flowing, slows the heart, moves the gut, and empties the bladder. An anticholinergic drug is a competitive antagonist at those receptors. Remove that cholinergic tone and every one of those actions reverses: the pupil dilates, sweating stops, the mouth and skin dry out, the heart speeds up, the gut goes quiet, and urine is retained. Centrally, muscarinic blockade in the brain produces an agitated, hallucinating delirium. That is the entire toxidrome — not a random collection of symptoms but the predictable shadow of a single missing signal. To see why each sign appears, it helps to have the Autonomic Nervous System chapter in mind: everything here is simply parasympathetic tone switched off.

The picture: six phrases every clinician memorizes

Generations of students have learned the anticholinergic patient through a string of similes, and they are worth knowing because each one maps to a receptor being blocked. "Blind as a bat" — dilated, unreactive pupils (mydriasis) and blurred near vision from paralysed accommodation. "Dry as a bone" — no sweat, no saliva, no tears: dry axillae and a tongue like sandpaper. "Red as a beet" — cutaneous flushing. "Hot as a hare" — hyperthermia, because a body that cannot sweat cannot dump heat, a genuinely dangerous feature. "Mad as a hatter" — an agitated, picking, hallucinating delirium. And "full as a flask" (or "a tick") — urinary retention from a bladder that won't contract. Round it out with a fast heart (tachycardia) and a silent, ileus-quiet abdomen with absent bowel sounds. Read those together and the diagnosis is usually clinical, before any level comes back from the laboratory.

The culprits: mostly on the pharmacy shelf

What makes this toxidrome so common is how many everyday drugs carry antimuscarinic activity, often as an unwanted side effect rather than their main job. The classic over-the-counter offenders are the sedating first-generation antihistamines — diphenhydramine and promethazine — which block H1 receptors (hence the drowsiness) but also happily block muscarinic ones. Tricyclic antidepressants (amitriptyline and its relatives) and many antipsychotics are strongly anticholinergic. Then come the drugs prescribed precisely for their antimuscarinic effect: the bladder antispasmodics like oxybutynin, atropine and hyoscine (scopolamine), and the antiparkinsonian agents such as benztropine and trihexyphenidyl. Finally, nature supplies its own: plants of the nightshade family — Datura (jimsonweed/thorn apple) and deadly nightshade (belladonna, the very source of atropine) — cause outbreaks of anticholinergic delirium in people who brew them for recreation or eat them by mistake. The breadth of the list is the point: fatigue, blurred vision and confusion in a patient on several of these should raise the toxidrome even without an overdose.

The one discriminator that matters: dry versus sweaty

Two toxidromes can put a hot, agitated, tachycardic patient in front of you — and the skin tells them apart. The anticholinergic picture overlaps almost perfectly with the sympathomimetic (stimulant) one taught in the Stimulant chapter: cocaine or amphetamine poisoning also gives agitation, dilated pupils, tachycardia, hypertension and hyperthermia. The single most useful bedside discriminator is the skin. Anticholinergic patients are bone-dry and flushed, because muscarinic blockade shuts the sweat glands off. Sympathomimetic patients are drenched in sweat, because catecholamine drive turns those same glands on hard. "Dry and mad" points to anticholinergics; "wet and wired" points to stimulants. That distinction — laid out in full in the Toxidromes chapter — is not academic: it steers everything downstream, because the antidote that safely calms an anticholinergic delirium is exactly the wrong move in a sympathomimetic (or a mixed) overdose.

Management: patience first, antidote rarely

For most anticholinergic poisonings the treatment is supportive and the patient does well with time, because the drug is eventually cleared. The priorities are simple and effective: benzodiazepines to control agitation and delirium (they calm the patient without adding anticholinergic effect), active cooling and intravenous fluids for hyperthermia, and a urinary catheter to relieve the retained bladder. Cardiac monitoring is mandatory — not to watch the sinus tachycardia, which rarely needs treatment, but to catch the QRS widening that betrays sodium-channel blockade. Activated charcoal may be considered for a large, recent ingestion in a patient whose airway is protected, though delayed gut motility limits its window. The great majority of patients need nothing more than a quiet room, a benzodiazepine, fluids and observation until the toxidrome fades.

Physostigmine: the antidote that reverses the whole picture

If the problem is too little acetylcholine at the receptor, raise it. Physostigmine is a carbamate cholinesterase inhibitor. By blocking acetylcholinesterase (AChE), it lets acetylcholine build up in the synapse and outcompete the antagonist at the muscarinic receptor — directly undoing the blockade. Its defining feature, and what makes it the antidote here, is that it is a tertiary amine that crosses the blood–brain barrier: unlike neostigmine (a charged quaternary compound stuck in the periphery), physostigmine reverses both the peripheral signs and the central delirium. Given to the right patient it is almost theatrical — the agitated, hallucinating patient becomes lucid and oriented within minutes. Its proper niche is a pure anticholinergic delirium: agitation or hallucinations severe enough to need control, in a patient in whom you are confident the cause is antimuscarinic alone. The same cholinesterase-inhibitor logic — more acetylcholine at the synapse — underlies the physostigmine and neostigmine described in the Autonomic Nervous System chapter, and it is the mirror image of organophosphate poisoning, where the enzyme is blocked pathologically rather than therapeutically.